Global Cancer Vaccines Market Report 2026–2030: Data-Driven Growth Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the cancer vaccines market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Cancer Vaccines Market be in 2030 compared with 2026?

The cancer vaccines market size has seen rapid growth in recent years. It is anticipated to expand from $9.36 billion in 2025 to $10.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.9%. The market’s historical growth can be linked to factors such as the increasing worldwide prevalence of cancer, the restricted efficacy of conventional cancer treatments, heightened awareness of cancer immunotherapy, escalating investment in oncology research, and prompt regulatory approvals for cancer vaccines.

The cancer vaccines market size anticipates significant expansion over the coming years, with projections indicating an increase to $18.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.3%. This anticipated growth is primarily driven by progress in vaccine platforms and their delivery methods, the increasing embrace of personalized cancer vaccines, the widening scope of clinical pipelines for therapeutic vaccines, an increase in government investment in cancer research, and the rising need for combined cancer therapies. Key developments during this period involve the surging creation of therapeutic cancer vaccines, a heightened emphasis on personalized and targeted immunotherapies, an increase in clinical trials for innovative cancer vaccine technologies, the broadening of preventive vaccination initiatives aimed at cancer prevention, and an uptick in partnerships between pharmaceutical companies and research institutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

What Drivers Are Guiding Growth Patterns In The Cancer Vaccines Market?

Increased governmental financial backing for research and development is anticipated to drive the expansion of the cancer vaccines market moving forward. Government funding refers to monetary resources provided by a government for a specific purpose. This funding for research and development is on the rise to stimulate innovation and accelerate the creation of new technologies and treatments capable of addressing crucial health and economic challenges. Cancer vaccines assist government funding for research and development by establishing prospects for investment in both preventative and therapeutic innovations, thereby encouraging greater financial support for vaccine research programs. For instance, in September 2023, the National Cancer Institute, a US-based government agency, received a budget of $7.3 billion from the United States Congress for fiscal year 2023, representing a $408 million increase over 2022. Therefore, the rise in government funding for research and development is propelling the growth of the cancer vaccines market.

Which Segments Are Driving Activity In The Cancer Vaccines Market?

The cancer vaccines market covered in this report is segmented –

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types

4) By End-User: Cancer Treatment Centers, Research Institutes

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines

2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines

Which Trends Are Shaping Activity Within The Cancer Vaccines Market?

Major companies operating in the cancer vaccines market are intensifying their focus on introducing quadrivalent vaccines to maximize revenue in the market. A quadrivalent vaccine is a type of vaccine that offers protection against four different strains or types of a specific virus or bacteria. For instance, in January 2023, Serum Institute of India, an India-based biotechnology company, launched CERVAVAC, the first made-in-India cervical cancer vaccine. This vaccine is designed to be effective against HPV types 16 and 18, as well as 6 and 11, which are responsible for at least 70% of cervical cancers. The vaccine will be administered via injection in two doses among 9–14-year-olds and three doses for those between 15 and 26.

Which Key Players Are Driving Competition In The Cancer Vaccines Market?

Major companies operating in the cancer vaccines market are GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Which Region Is Projected To Lead The Cancer Vaccines Market During The Forecast Period?

North America was the largest region in the cancer vaccines market in 2025. The regions covered in the cancer vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cancer Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3452&type=smp

Browse Through More Reports Similar to the Global Cancer Vaccines Market 2026, By The Business Research Company

Veterinary Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Therapeutic Proteins Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795